Correlation Between Monopar Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Monopar Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Anebulo Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Monopar and Anebulo is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.02 times more return on investment than Anebulo Pharmaceuticals. However, Monopar Therapeutics is 1.02 times more volatile than Anebulo Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 1,783 in Monopar Therapeutics on August 28, 2024 and sell it today you would earn a total of 157.00 from holding Monopar Therapeutics or generate 8.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Monopar Therapeutics |
| Anebulo Pharmaceuticals |
Monopar Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |